Specialty Pharmacy

Increasing number of urology practices working with specialty pharmacies.

The FDA has granted Breakthrough Therapy Designation to Roche's tocilizumab (Actemra/RoActemra) for the treatment of systemic sclerosis.

The federal Drug Quality and Security Act was signed into law in 2013 with the intent to hold pharmacy stakeholders accountable for identifying suspect drug products and reporting related issues.

Men with AR-V7 variant more likely to be resistant to hormone drugs.

Researchers find cooperation among viral variants that help hepatitis C to survive.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, Inc, discusses methods to address the growing cost of specialty medications.

Drug is being evaluated for the treatment of patients who received at least 3 prior lines of therapy.

The FDA has approved Novartis's eltrombopag (Promacta) to treat a rare, chronic blood disorder in children.

In addition to treating hepatitis B virus infection, Novartis's antiviral drug telbivudine effectively protects against mother-to-infant transmission.

Undertreated side effects in treatment of some colon and stomach cancers need to be addressed.

Comprehensive screening guidelines needed for populations with multiple risk factors.

Provider status legislation may be the signature pharmacy policy issue of 2015.

Pharmacy technicians with special certifications are taking on expanded roles in medication delivery.

Costs grow for people with oral cavity and pharyngeal cancers based on demographics, co-existing illnesses, and treatment selection.

Biological mechanisms of breast milk may have preventative effect.

Nivolumab extends life by 3.2 months compared with chemotherapy.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the National Association for Specialty Pharmacy and their efforts to enhance the specialty space.

The FDA has granted breakthrough therapy designation to Genzyme's olipudase alfa enzyme replacement treatment for nonneurological manifestations of acid sphingomyelinase deficiency.

Health-system pharmacists are facing inevitable challenges to ethics and autonomy embedded in their evolving everyday practice.

Could changes in the physical attributes of generic drugs affect patient adherence? The FDA seeks to survey pharmacists and patients to find out.

Nivolumab has increased the survival rate in patients with low grade adverse events.

A look back at the top stories of the week on Specialty Pharmacy Times.

Extracts show strong activity in treatment of cervical cancer cells.

Top news of the week from the annual meeting of the American Society of Clinical Oncology.

Drug found to improve physical function.

Combination therapy with AKT inhibitors shows promise.

Operations halted after vials of albumin were found to have fungal contamination.

Marketplace users less likely to use most medication classes except for hepatitis C and HIV.